Acrylic Acid

Acrylic Acid

SCHEMBL28154241

C=CC(=O)[O-].C=CC(=O)[O-].OCCO.[Zn+2]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.40
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40
LMNA P02545 1/20 0.37
ALDH1A1 P00352 6/20 0.35
FGFR4 P22455 1/20 0.35
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 2/20 0.31
CYP3A4 P08684 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
CA4 P22748 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL28132846 0.94 TSHR (0.40) TSHRCA1CA9LMNAALDH1A1
Acrylic Acid SCHEMBL27885156 0.94 TSHR (0.40) TSHRCA1CA9LMNAALDH1A1
Acrylic Acid SCHEMBL27704158 0.94 CA1 (0.46) TSHRCA1CA9LMNAALDH1A1
Acrylic Acid SCHEMBL27935223 0.94 TSHR (0.40) TSHRCA1CA9LMNAALDH1A1
Acrylic Acid SCHEMBL29486337 0.87 LMNA (0.47) TSHRCA1LMNAALDH1A1FGFR4
Acrylic Acid SCHEMBL56817 0.87 LMNA (0.47) TSHRCA1LMNAALDH1A1FGFR4
Acrylic Acid SCHEMBL15641414 0.84 LMNA (0.39) TSHRCA1CA9LMNAALDH1A1
Acrylic Acid SCHEMBL9394950 0.83
Acrylic Acid SCHEMBL11529572 0.83 LMNA (0.44) TSHRCA1LMNAALDH1A1FGFR4
Acrylic Acid SCHEMBL8887939 0.83 LMNA (0.44) TSHRCA1LMNAALDH1A1FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106784840-A A kind of preparation method of the metal negative electrode protective layer with electro-chemical activity 中国人民解放军63971部队 2017-05-31 CN disclosed